ZA761346B - Vaccine for active immunization containing hepatitis b surface antigen and associated antigen - Google Patents

Vaccine for active immunization containing hepatitis b surface antigen and associated antigen

Info

Publication number
ZA761346B
ZA761346B ZA761346A ZA761346A ZA761346B ZA 761346 B ZA761346 B ZA 761346B ZA 761346 A ZA761346 A ZA 761346A ZA 761346 A ZA761346 A ZA 761346A ZA 761346 B ZA761346 B ZA 761346B
Authority
ZA
South Africa
Prior art keywords
vaccine
antigen
active immunization
containing hepatitis
immunization containing
Prior art date
Application number
ZA761346A
Other languages
English (en)
Inventor
Alfred Mayer Prince
Mayer Prince Alfred
C Trepo
J Vnek
A Neurath
Original Assignee
Community Blood Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Community Blood Council filed Critical Community Blood Council
Publication of ZA761346B publication Critical patent/ZA761346B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
ZA761346A 1975-03-14 1976-03-05 Vaccine for active immunization containing hepatitis b surface antigen and associated antigen ZA761346B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7508046A FR2303562A1 (fr) 1975-03-14 1975-03-14 Nouvelle preparation d'antigene utilisable comme vaccin

Publications (1)

Publication Number Publication Date
ZA761346B true ZA761346B (en) 1977-02-23

Family

ID=9152597

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA761346A ZA761346B (en) 1975-03-14 1976-03-05 Vaccine for active immunization containing hepatitis b surface antigen and associated antigen

Country Status (4)

Country Link
US (1) US4118479A (fr)
BE (1) BE839306A (fr)
FR (1) FR2303562A1 (fr)
ZA (1) ZA761346B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2750045A1 (de) * 1977-11-09 1979-05-10 Behringwerke Ag Verfahren zur entfernung von detergentien aus virusantigensuspensionen
US4181713A (en) * 1978-10-30 1980-01-01 Merck & Co., Inc. Isolation of HBs Ag
JPS5610119A (en) * 1979-07-05 1981-02-02 Alpha Therapeutic Corp Manufacture of b type hepatitis infection preventive vaccine
US4412985A (en) * 1980-10-06 1983-11-01 Edward Shanbrom Depyrogenation process
US4617260A (en) * 1981-02-27 1986-10-14 Merck & Co., Inc. RIA assay for HBcAg
PL133476B1 (en) * 1981-06-10 1985-06-29 Akad Medyczna Method of obtaining pure antigen hba from human serum
AU8746582A (en) * 1981-09-02 1983-03-10 Biogen N.V. Hepatitis b virus e type antigen
GB8321789D0 (en) * 1983-08-12 1983-09-14 Biogen Nv Vaccines and compositions against hepatitis
US5324513A (en) * 1984-03-07 1994-06-28 Institut Pasteur Composition useful for the fabrication of vaccines
US4649192A (en) * 1985-05-30 1987-03-10 Smith Kline-Rit Method for the isolation and purification of hepatitis B surface antigen using polysorbate
CA2178635C (fr) * 1993-12-10 2004-05-25 Yu-Wen Hu Titrage par immunofluorescence concernant la detection d'anticorps et utilisant des antigenes recombines sous forme non soluble

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1356413A (en) * 1971-09-09 1974-06-12 Pfizer Ltd Method of obtaining purified australia antigen from blood serum
US3951937A (en) * 1973-12-20 1976-04-20 The Community Blood Council Of Greater New York, Inc. Large scale purification of hepatitis type B antigen using polyethylene glycol
US3976767A (en) * 1975-04-14 1976-08-24 The New York Blood Center Purification of hepatitis B surface antigen by chromatography on agarose containing aminoalkyl residues

Also Published As

Publication number Publication date
FR2303562A1 (fr) 1976-10-08
FR2303562B1 (fr) 1978-08-04
US4118479A (en) 1978-10-03
BE839306A (fr) 1976-07-01

Similar Documents

Publication Publication Date Title
IL47177A0 (en) Antipregnancy vaccine
GB1546140A (en) Vaccine delivery method
AU506385B2 (en) Hepatitis b virus; isolation for vaccines
AU504454B2 (en) Hepatitis b antigen and vaccine
JPS57203016A (en) Hepatitis b antigen
ZA774733B (en) Vaccines
ZA761346B (en) Vaccine for active immunization containing hepatitis b surface antigen and associated antigen
AU2949677A (en) Cancer-testing and immunization
JPS5244228A (en) Antigenic medicine
GB2053233B (en) Vaccinating cyclopeptidic antigenic fraction process for isolating it and vaccines containing it
AU1807776A (en) Detecting hepatitis antigen and antibodies and vaccine for hepatitis
IL51864A0 (en) Rabies vaccine and its preparation
JPS51121266A (en) Method of removing projected portion of epitaxial layer
AU505999B2 (en) Hepatitis vaccine
GB1551437A (en) Rabies virus vaccine and processes
JPS52130907A (en) Removement of hepatitis related antigen from plasma
ZA803845B (en) Polyvalent virus vaccines
GB1543962A (en) Acellular vaccines
HU178166B (en) Process for preparing immunologically active polyribosyl-ribitol-phosphate and vaccine containing thereof
IE800696L (en) Porcine pleuropneumonia vaccine
JPS51142528A (en) Production of vaccine based on antigenic libosome fractionation
JPS51151322A (en) Antigen composition
JPS52134019A (en) Micoplasma galicepticum infection vaccine
AU517019B2 (en) Brucellosis vaccine and method
AU1050276A (en) Preservation of vaccines